The global burden of HIV

Clin Dermatol. 2024 Mar-Apr;42(2):119-127. doi: 10.1016/j.clindermatol.2024.02.001. Epub 2024 Feb 21.

Abstract

The global burden of HIV remains a formidable challenge, affecting millions. Despite significant progress in understanding, treatment, and prevention , HIV/AIDS continues to exert a substantial impact on personal and public health, particularly in sub-Saharan Africa, where the prevalence is highest. HIV not only poses a direct threat to the well-being of individuals but also contributes to social and economic disparities. Approximately 38 million people worldwide are living with HIV, with millions unaware of their status. Stigma and discrimination still hinder testing, starting and staying on treatment. Access to antiretroviral therapy has improved, yet disparities persist, with marginalized communities often facing barriers to essential health care services. Efforts to reduce new HIV infections and transmission include comprehensive prevention strategies, education, and increased access to testing and treatment. Addressing social determinants, reducing stigma, and ensuring equitable access to health care remain crucial to reach the ambitious goal of ending AIDS by 2030.

MeSH terms

  • Acquired Immunodeficiency Syndrome* / drug therapy
  • Acquired Immunodeficiency Syndrome* / epidemiology
  • Acquired Immunodeficiency Syndrome* / prevention & control
  • Africa South of the Sahara / epidemiology
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Humans
  • Prevalence